Comp C-National Spina Bifida Patient Registry/Urological Component

Information

  • Research Project
  • 9319022
  • ApplicationId
    9319022
  • Core Project Number
    U01DD001060
  • Full Project Number
    5U01DD001060-04
  • Serial Number
    001060
  • FOA Number
    RFA-DD-14-002
  • Sub Project Id
  • Project Start Date
    9/1/2014 - 9 years ago
  • Project End Date
    8/31/2019 - 4 years ago
  • Program Officer Name
    DARLING, NATALIE
  • Budget Start Date
    9/1/2017 - 6 years ago
  • Budget End Date
    8/31/2018 - 5 years ago
  • Fiscal Year
    2017
  • Support Year
    04
  • Suffix
  • Award Notice Date
    7/21/2017 - 7 years ago
Organizations

Comp C-National Spina Bifida Patient Registry/Urological Component

DESCRIPTION (provided by applicant): Spina bifida (SB) is the most common permanently disabling birth defect in the United States. There exists a broad spectrum in the degree to which this condition impairs each individual patient. In addition, SB involves multiple organ systems. As a result, the care of such patients is complex, requires multiple specialists and must be individualized to each patient's degree of impairment within each organ system. This has made it difficult to create evidence-based algorithms for management of spina bifida patients with mostly retrospective and incomplete data to rely on. Spina bifida can inhibit proper bladder function due to loss of normal bladder innervation. This can result in high bladder pressures, which over time can lead to hydronephrosis, vesicoureteral reflux, incontinence, urinary tract infections and renal insufficiency. The primary goal of urologic management in patients with SB is preservation of renal function. Secondary goals include prevention of urinary tract infection and achieving acceptable urinary continence. Practice patterns in the management of newborns and small children with SB vary across different institutions and regions. There are currently limited prospective data on protocols to manage these patients with clear outcomes related to renal function. The primary goal of this study is to implement and evaluate a protocol for the urologic management and follow- up of infants and young children with SB across 10 different institutions. Measures of renal function at five years of age will serve as the primary outcome for the study. Secondary outcomes will include cost- effectiveness of the protocol and frequency of urinary tract infections. Results of this prospective study will be used to compare with outcomes in renal function and urinary tract infection at other institutions involved in the recently create National Spina Bifida Patient Registry. This proposal supports the overall mission of the Centers for Disease Control and Prevention by helping protect this vulnerable population and establishing standards of care that will promote improved health among patients with SB.

IC Name
National Center on Birth Defects and Developmental Disabilities
  • Activity
    U01
  • Administering IC
    DD
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    20530
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NCBDD:20530\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZDD1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    IHC HEALTH SERVICES, INC.
  • Organization Department
  • Organization DUNS
    072955503
  • Organization City
    SALT LAKE CITY
  • Organization State
    UT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    841111470
  • Organization District
    UNITED STATES